SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-017914
Filing Date
2022-08-30
Accepted
2022-08-30 16:22:30
Documents
12
Period of Report
2022-08-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K eypt-20220826.htm   iXBRL 8-K 48927
  Complete submission text file 0000950170-22-017914.txt   160993

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eypt-20220826_pre.xml EX-101.PRE 9457
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eypt-20220826_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eypt-20220826.xsd EX-101.SCH 2475
6 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20220826_htm.xml XML 4523
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 221214816
SIC: 3826 Laboratory Analytical Instruments